key takeaways in leukemia at asco 2022
Published 2 years ago • 89 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:08
key takeaways in hemonc at asco 2022
-
2:02
highlights in the field of lymphoma from asco 2022
-
1:20
mpns at asco 2022: cytopenic myelofibrosis, non-jak inhibitor approaches & combination therapy
-
1:53
role of ngs in acute leukemias
-
1:19
outcomes of cll patients following treatment with a covalent btk and bcl2 inhibitor
-
12:51
acute leukemias at the t-lymphoid/myeloid interface
-
3:04
head and neck cancer at asco 2022
-
1:49
advances in the science and treatment of mpns
-
17:25
adrian mosquera - artificial intelligence: applications in multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:26
combining btk and bcl-2 inhibitors for the treatment of cll
-
2:44
myeloma qol through induction and maintenance
-
3:30
treatment options for young, newly diagnosed & low-risk patients with cll
-
1:22
highlights from comy 2022: day 1
-
3:33
the growing role of machine learning in hematological oncology
-
2:14
key population-based registry studies in hematological oncology
-
1:25
car-t in mm: karmma, cartitude-1 and evolve
-
2:21
the role of daratumumab in the treatment of myeloma and insights into the maia trial
-
4:39
aml & mds: mac or ric?
-
0:59
idh inhibitors in aml